Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (82)

« Back to Publications

Investigating ethnicity-related variability in the human L-cone spectral sensitivity function

Schneider AC. et al, (2026), Vision Research, 243, 108769 - 108769

Gene Therapy Strategies for the Treatment of Bestrophinopathies.

Haldrup SB. et al, (2025), Int J Mol Sci, 26

CRISPR targeting of SNPs associated with age-related macular degeneration in ARPE-19 cells: a potential model for manipulating the complement system

Salman A. et al, (2025), Gene Therapy, 32, 132 - 141

Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration

Fry LE. et al, (2025), Communications Biology, 8

Gene Therapies in Clinical Development to Treat Retinal Disorders

McClements ME. et al, (2024), Molecular Diagnosis & Therapy, 28, 575 - 591

Genetic therapies and potential therapeutic applications of CRISPR activators in the eye.

Ng BW. et al, (2024), Prog Retin Eye Res, 102

Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis

Quinn J. et al, (2024), Scientific Reports, 14

CRISPR targeting of SNPs associated with Age-related Macular Degeneration in ARPE-19 cells: a potential model for manipulating the complement system

Salman A. et al, (2024)

Rescue of cone and rod photoreceptor function in a CDHR1-model of age-related retinal degeneration

Yusuf IH. et al, (2024), Molecular Therapy, 32, 1445 - 1460

CRISPR Manipulation of Age-Related Macular Degeneration Haplotypes in the Complement System: Potential Future Therapeutic Applications/Avenues

Salman A. et al, (2024), International Journal of Molecular Sciences, 25, 1697 - 1697

Programmable RNA editing with endogenous ADAR enzymes – a feasible option for the treatment of inherited retinal disease?

Bellingrath J-S. et al, (2023), Frontiers in Molecular Neuroscience, 16

A Review of CRISPR Tools for Treating Usher Syndrome: Applicability, Safety, Efficiency, and In Vivo Delivery.

Major L. et al, (2023), Int J Mol Sci, 24

Erratum: Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues.

Chandler LC. et al, (2023), Mol Ther Methods Clin Dev, 28

Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases.

Hansen S. et al, (2023), Cells, 12

Impaired glutamylation of RPGR ORF15 underlies the cone-dominated phenotype associated with truncating distal ORF15 variants

Cehajic-Kapetanovic J. et al, (2022), Proceedings of the National Academy of Sciences, 119

Load More

1
2
3
4
5
6